Polypyrrole Nanoparticles: A Potential Optical Coherence Tomography Contrast Agent for Cancer Imaging
- 21 November 2011
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 23 (48), 5792-5795
- https://doi.org/10.1002/adma.201103190
Abstract
A near-infrared (NIR) absorbing contrast agent based on polypyrrole nanoparticles is described. Quantitative optical coherence tomography studies on tissue phantoms and Mie scattering calculations indicate their potential application for early-stage cancer diagnosis.Keywords
This publication has 38 references indexed in Scilit:
- Contrasting properties of gold nanoparticles for optical coherence tomography: phantom,in vivostudies and Monte Carlo simulationPhysics in Medicine & Biology, 2008
- Optical coherence tomography: a review of clinical development from bench to bedsideJournal of Biomedical Optics, 2007
- Optical probes and techniques for molecular contrast enhancement in coherence imagingJournal of Biomedical Optics, 2005
- Optical Coherence Tomography: Feasibility for Basic Research and Image-guided Surgery of Breast CancerBreast Cancer Research and Treatment, 2004
- Optical coherence tomography to detect and manage retinal disease and glaucomaAmerican Journal of Ophthalmology, 2004
- Sensitivity advantage of swept source and Fourier domain optical coherence tomographyOptics Express, 2003
- IN VIVO OPTICAL COHERENCE TOMOGRAPHY FEASIBILITY FOR BLADDER DISEASEJournal of Urology, 2002
- In Vivo Endoscopic Optical Biopsy with Optical Coherence TomographyScience, 1997
- Optical biopsy and imaging using optical coherence tomographyNature Medicine, 1995
- Optical Coherence TomographyScience, 1991